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Abstract Blepharophimosis–Ptosis–Epicanthus inversus
syndrome (BPES) is a well-characterized rare syndrome
that includes an eyelid malformation associated with (type
I) or without premature ovarian failure (type II). Patients
with typical BPES have four major characteristics: blepha-
rophimosis, ptosis, epicanthus inversus and telecanthus.
Mutations in the FOXL2 gene, encoding a forkhead tran-
scription factor, are responsible for the majority of both
types of BPES. However, many patients with BPES-like
features, i.e., having at least two major characteristics of
BPES, have an unidentiWed cause. Here, we report on a
group of 27 patients with BPES-like features, but without
an identiWed genetic defect in the FOXL2 gene or Xanking
region. These patients were analyzed with whole-genome
high-density arrays in order to identify copy number vari-
ants (CNVs) that might explain the BPES-like phenotype.
In nine out of 27 patients (33%) CNVs not previously
described as polymorphisms were detected. Four of these
patients displayed psychomotor retardation as an additional
clinical characteristic. In conclusion, we demonstrate that
BPES-like phenotypes are frequently caused by CNVs, and
we emphasize the importance of whole-genome copy num-
ber screening to identify the underlying genetic causes of
these phenotypes.
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Blepharophimosis and ptosis are a reduction in the horizon-
tal and vertical dimensions of the palpebral Wssures respec-
tively (Guercio and Martyn 2007). From 135 syndromes in
the London Dysmorphology Database with blepharophimo-
sis and ptosis, six are known to be associated with a chro-
mosomal microdeletion (Winter and Baraitser 2008). In
addition, a recent literature review illustrates that chromo-
somal aberrations are probably the most important underly-
ing cause in patients with blepharophimosis and mental
retardation phenotypes (Bartholdi et al. 2008). Only a few
blepharophimosis syndromes have known causative genes:
the Schwartz–Jampel syndrome (OMIM 255800), Freeman
Sheldon syndrome (OMIM 193700), Hereditary neuralgic
amyotrophy syndrome (HNA; OMIM 162100) (Laccone
et al. 2008) and Blepharophimosis–Ptosis–Epicanthus
inversus syndrome (BPES) (OMIM 110100). BPES is a
rare autosomal dominant disorder characterized by a dys-
plasia of the eyelids. There are two types of clinical presen-
tation: type I is associated with premature ovarian failure,
whereas type II has no associated symptoms (Zlotogora
et al. 1983). The typical BPES phenotype is characterized
by four major features blepharophimosis, ptosis, epicanthus
inversus (a small skin fold which arises from the lower eye-
lid and runs inwards and upwards) and telecanthus
(increased distance between the medial lid margins). Hap-
loinsuYciency of the FOXL2 gene, encoding a putative
forkhead transcription factor located at chromosome 3q23,
is responsible for both types of BPES (Crisponi et al. 2001;
De Baere et al. 2001, 2003). Using a combined mutation
detection approach, it is possible to reveal the causal
genetic defect in 88% of typical BPES patients. Molecular
defects include chromosomal rearrangements (2%), intra-
genic mutations (81%) and genomic rearrangements com-
prising both deletions encompassing FOXL2 (12%) and
deletions located outside its transcription unit (5%) (Beysen
et al. 2005, 2008). The lack of a detectable genetic FOXL2
defect might be explained by several grounds, including
subtle extragenic rearrangements, epigenetic changes and
referral bias by the diVerent clinicians (Beysen et al. 2008).
Here, we focus on series of 27 patients with BPES-like fea-
tures (i.e., having at least two main characteristics of typi-
cal BPES), who tested negative for FOXL2 mutations and
deletions of the FOXL2 region, and in whom the causal
defect remains to be elucidated (Beysen et al. 2008).
Novel whole-genome array-based technologies can
detect copy number variants (CNVs) at much higher resolu-
tion than conventional cytogenetic methods, and hence
might reveal CNVs that were previously unidentiWed.
These techniques have been used with considerable success
to reveal de novo CNVs in several phenotypes, including
mental retardation and dysmorphism (Stankiewicz and
Beaudet 2007; Slavotinek 2008).Yet, the association
between CNVs and BPES-like phenotypes has not been
investigated. We performed whole-genome high-density
arrays in the group of 27 FOXL2 mutation-negative patients
with a BPES-like phenotype in order to identify the under-
lying genetic cause explaining the phenotypes.
Methods
Patients
Genomic DNA was obtained from 27 patients with a
BPES-like phenotype, being patients for whom at least two
of the four diagnostic criteria of BPES (i.e., blepharophi-
mosis, ptosis, epicanthus inversus and telecanthus), were
mentioned on a clinical questionnaire. In 11 of the patients
psychomotor retardation was identiWed as an additional
clinical feature. Furthermore, all patients were clinically
assessed by diVerent clinicians. The patients were recruited
in three genetic centers: (1) 22 patients from the Center for
Medical Genetics, Ghent University Hospital, Belgium.
Genomic patient DNA was used that was available from
previously approved mutation studies (De Baere et al.
2001, 2003; Beysen et al. 2005, 2008), (2) three families
from the Department of Clinical Genetics, Amsterdam
Medical Centre, The Netherlands, (3) two patients from the
Department of Clinical Genetics, Leiden University Medi-
cal Center, The Netherlands.
All patients were initially referred for FOXL2 screening.
Intragenic FOXL2 mutations and copy number variants of
the FOXL2 gene and surrounding region were excluded in
all patients by sequencing of the coding region and multi-
plex ligation-dependent probe ampliWcation (MLPA)
(P054, MRC Holland). In addition, conventional karyotyp-
ing was performed in 13 patients and considered normal.
Single nucleotide polymorphism arrays
AVymetrix GeneChip Human Mapping 262 K NspI.  This
array was used for one patient and his parents. This SNP
array contains »262,000 25-mer oligonucleotides with an
average spatial resolution of »12 kb. An amount of 250 ng
DNA was processed according to the manufacturer’s instruc-
tion (http://www.affymetrix.com). SNP copy number was
assessed in the patient using DNA-Chip Analyzer (dChip)
software (version release 02-16-06) (Li and Wong, 2001).
Illumina’s Sentrix HumanHap300 Genotyping Beadchip
This platform was used for 23 patients. This array
contains »317,000 TagSNPs with a mean spatial resolu-
tion of approximately 9 kb. A total of 750 ng DNA was
processed according to the manufacturer’s instruction123
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and B allele frequency were assessed in the patients using
BeadStudio Version 3.2 (Illumina, Inc.).
Illumina’s HumanCNV370-Duo BeadChip.  For three
patients this platform was used. This array contains
»317,000 TagSNPs and 52,000 non-polymorphic markers
to speciWcally target nearly 14,000 known copy number
variants with a mean spatial resolution of approximately
7.7 kb. The experiment was performed as described above.
SNP copy number and B allele frequency were assessed in
BeadStudio, Version 3.2 (Illumina, Inc.).
Evaluation of CNVs
Based on in-house validation studies deletions of at least
Wve adjacent SNPs or with a minimum size of 150 kb and
duplications of at least seven adjacent SNPs or with a mini-
mum size of 200 kb were considered signiWcant. All CNVs
identiWed in this study were assessed by screening them
against the Database of Genomic Variants (DGV) (http://
projects.tcag.ca/variation/) and against our in-house avail-
able reference set of approximately 1,000 individuals. All
regions that signiWcantly overlapped with known polymor-
phic CNVs were excluded from further research.
MLPA
MLPA experiments were carried out to validate the pres-
ence of deletions and duplications identiWed by the arrays.
When an aberration was conWrmed by MLPA, the same
probe set was used to perform segregation analysis in the
parents (if available). At least two synthetic MLPA probes
were designed within the aberration and MLPA experi-
ments were performed as described (White et al. 2004).
Probes were commercially obtained from Biolegio
(Malden, The Netherlands). AmpliWcation products were
identiWed and quantiWed by capillary electrophoresis on an
ABI 3130 genetic analyzer (Applied Biosystems, Nieu-
werkerk aan de IJssel, The Netherlands). Fragment analy-
sis was performed with the GeneMarker Software V1.51
(SoftGenetics, USA). Thresholds for deletions and dupli-
cations were set at 0.75 and 1.25, respectively (White et al.
2004).
Fluorescent in situ Hybridization analysis (FISH)
Fluorescent in situ Hybridization analysis was carried out
by standard procedures as described (Dauwerse et al.
1990). FISH analysis was performed to verify the imbal-
ances found with the array experiments and to exclude
more complex rearrangements. BAC clones mapping to the
unbalanced chromosome regions were selected based on
their physical location within the aVected region (http://
www.ensembl.org: Ensembl release 48 December 2007).
Gene prioritisation
The software tool Anni 2.0 (http://www.biosemantics.org/
Anni) was used to search for potential candidate genes for
BPES-like features in the CNVs found. For each gene a
proWle of related concepts is constructed that summarizes
the context in which the gene is mentioned in the literature.
Genes associated with similar topics are identiWed by hier-
archical clustering of the corresponding gene concept pro-
Wles. The software was used according to the software’s
manual (Jelier et al. 2007).
Results and discussion
IdentiWcation and conWrmation of 12 signiWcant CNVs
In this study we included 27 patients based on the following
criteria: (1) BPES-like phenotype (i.e., 2 or more major fea-
tures of BPES, with or without additional dysmorphic fea-
tures and psychomotor retardation), (2) exclusion of a
FOXL2 mutation or deletion of the FOXL2 region. These
patients were analyzed with whole-genome high-density
arrays with an average spatial resolution of approximately
10 kb, in an attempt to identify the underlying genetic cause
and to reveal potential novel candidate loci and genes for
BPES-like phenotypes.
In total we identiWed 12 CNVs not previously
described in phenotypically normal individuals according
to the DGV and our in-house reference set, in nine out of
27 patients (33%). An overview of these changes is pro-
vided in Table 1. We found six duplications and six dele-
tions. In three patients (cases 7, 8 and 9) a deletion as well
as duplication was identiWed, suggesting the presence of
an unbalanced translocation. The identiWed CNVs vary in
size from 485 kb to 21.9 Mb. Table 2 represents the avail-
able clinical features from eight out of the nine patients
carrying chromosome imbalances. Four of these patients
display psychomotor retardation as an additional clinical
feature.
Each of the 12 CNVs was conWrmed by a second inde-
pendent technique, either MLPA (patients 1–3, 5, 7–8),
FISH (patients 4, 9) or another SNP array platform (patient
6). In eight of nine cases parental DNA was available for
segregation analysis. MLPA and FISH analysis in these
cases determined that chromosomal aberrations arose de
novo in Wve out of eight individuals (patients 1–4, 8).123
492 Hum Genet (2008) 124:489–498De novo single CNVs
The CNVs identiWed in cases 1 and 2 were recently
described in patients with BPES-like features, developmen-
tal delay and other dysmorphic features (Schinzel et al.
1991; Tinkle et al. 2003; Shaw-Smith et al. 2006; Koolen
et al. 2006; Koolen et al. 2008).
Patient 1 had an interstitial deletion of 18q12.2q21.1
(14.3 Mb), and displayed blepharophimosis, ptosis, epican-
thus inversus and mild dysmorphic features (abnormal nose
and ears). The patient died at the age of 4. Several cases
have been described with del(18)(q12.2q21.1) showing a
consistent clinical pattern of mild dysmorphic features,
blepharophimosis, obesity, mental retardation, seizures,
behavioral problems and lack of major congenital anoma-
lies (Schinzel et al. 1991; Tinkle et al. 2003).
In patient 2 an interstitial microdeletion of 17q21.31
(485 kb) was found (Fig. 1), overlapping with the region
that was recently described in the new microdeletion syn-
drome 17q21.31 (Shaw-Smith et al. 2006; Koolen et al.
2006). This new microdeletion syndrome was originally
identiWed by high-resolution genome analyses in patients
with unexplained mental retardation, and was recently fur-
ther characterized clinically and molecularly (Koolen et al.
2008). The deletions are associated with a common inver-
sion polymorphism. Individuals carrying this deletion dis-
play a recognizable phenotype of blepharophimosis, a
characteristic long face with pear shaped nose, large ears,
hypotonia and mental retardation. Interestingly, the pheno-
type of patient 2, characterized by blepharophimosis, bilat-
eral ptosis, epicanthus inversus, telecanthus, broad pear
shaped nose, large ears, central and peripheral hypotonia
and psychomotor retardation, is in agreement with this rec-
ognizable 17q21.31 microdeletion syndrome.
Patient 3 had a small interstitial duplication of 16p13.3
(1.1 Mb). To our knowledge, two patients have been
reported with a partially overlapping duplication of this
region, including a patient with an interstitial duplication
of 345–480 kb on 16p13.3, encompassing the TRAP1 and
CREBBP genes that are also duplicated in patient 3
(Thienpont et al. 2007). The second patient was reported
to have a duplication of 16p13.3 with a minimal and max-
imal size of 4.5 and 7 Mb, respectively (de Ravel et al.
2005). The duplicated region of patient 3 overlaps over at
least 620 kb with the reported duplications. However, the
two reported patients display no BPES-like features, sug-
gesting that the region of approximately 600 kb that does
not overlap is responsible for the BPES-like features in
patient 3.
In patient 4 we detected a novel rearrangement, being
an interstitial deletion of chromosome 10p12.33p12.31
(4.5 Mb) (Fig. 2). It was shown to occur de novo and it is
therefore likely to be causative. The clinical features of this
patient include blepharophimosis, ptosis, epicanthal folds,
ectropion of the lower eyelid, S-shaped upper eyelid, syn-
ophrys, high palate, broad hands and feet, and an atrial sep-
tal defect type II. This patient has a normal psychomotor
development.
Table 1 CNVs detected by whole-genome high-density SNP arrays
I AVymetrix GeneChip Human Mapping 262 K NspI, II Illumina’s Sentrix HumanHap300 Genotyping Beadchip, NA parental DNA not available
a First aberrant probe
b Last aberrant probe
c Minimal size of aberration
d Paternal inheritance can be concluded from the pedigree (see Fig. 3c)








1 Loss 18q12.2q21.1 rs1693336 rs2576050 14.3 Mb II MLPA de novo 18
2 Loss 17q21.31q21.31 rs393152 rs2016730 485 kb II MLPA de novo 3
3 Gain 16p13.3p13.3 rs11077336 rs2239316 1.1 Mb II MLPA de novo 21
4 Loss 10p12.33p12.31 rs17140331 rs11012683 4.5 Mb I FISH de novo 7
5 Gain 11p15.4p15.4 rs7117223 rs4237772 545 kb II MLPA Maternal 5
6 Gain 9q34.1q34.2 rs3012755 rs2027963 1.4 Mb II I Maternal 23
7 Gain 10q25.2 rs10885243 rs9630042 21.9 Mb II MLPA NA 61
Loss 11q24.3 rs1940363 rs4508216 5 Mb II MLPA NA 18
8 Gain 3q29 rs1021662 rs12639242 4 Mb II MLPA de novo 43
Loss 13q33.3 rs7321084 rs7316983 5 Mb II MLPA de novo 36
9 Loss 3p25.3 rs9681213 rs3774210 8.6 Mb II FISH Paternald 12
Gain 6p24.3 rs6596796 rs927402 7.7 Mb II FISH Paternald 23123
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In patient 5 a small interstitial duplication of 545 kb on
chromosome 11p15.4 was detected. This gain was not
reported as a variant in the DGV, but was found in the phe-
notypically normal mother of this patient, probably sug-
gesting the absence of a causal relation between the
duplication and the BPES-like phenotype in the child.
Furthermore, in case 6 an interstitial duplication of chro-
mosome 9q34.1q34.2 (1.4 Mb) was found that was not
described in the DGV. The mother of this patient was shown
to carry the same duplication. The phenotype of patient 6 is
characterized by bilateral ptosis, mild epicanthus inversus,
horizontal nystagmus and high hypermetropia, while her
mother displayed a mild ptosis and strabismus for which she
underwent surgery. The occurrence of a phenotype in
mother and child might suggest a causal relationship of the
novel duplication and the phenotype.
Complex CNVs
In three cases more complex rearrangements were identi-
Wed (cases 7, 8 and 9). In these patients both duplication
and deletion were found on diVerent chromosomes, sug-
gesting the occurrence of an unbalanced translocation
(Table 1). Patient 7 was found to carry a terminal duplica-
tion of chromosome 10q (21.9 Mb) and a terminal deletion
of chromosome 11q (5 Mb). Recently, a patient was
described with approximately the same duplication of chro-
mosome 10q and a deletion located on chromosome 4q
(Bartholdi et al. 2008). This patient displayed the following
clinical features: blepharophimosis, ptosis, epicanthus
inversus, downslanting palpebral Wssures, generalized
hypotonia and developmental delay. The phenotype was
ascribed to the duplication of chromosome 10q (Bartholdi
et al. 2008). Our patient 7 showed a similar phenotype;
therefore, we hypothesize that the duplication of chromo-
some 10q might contribute to the BPES-like phenotype in
this patient. For patient 7 it could not be conWrmed whether
this complex rearrangement arose from a balanced translo-
cation in one of the parents.
Patient 8 showed a terminal duplication of chromosome
3q (4 Mb) and a terminal deletion of chromosome 13q
(5 Mb). FISH analysis revealed the presence of an unbal-
anced translocation in the patient and showed no abnormal-
ities in the parents. This patient showed a BPES-like
phenotype and some additional dysmorphic features. In
the ECARUCA database 28 cases were listed with a
del(13)(q33.3q34). In 4/28 blepharophimosis was described
as a clinical feature, in 3/28 ptosis, and in 2/28 telecanthus.
No association between BPES-like features and 3q29 could
be found in the literature.
Fig. 1 Case 2. a Deletion of chromosome 17q21.31 (485 kb) found
with the Illumina’s Sentrix HumanHap300 Genotyping Beadchip.
b MLPA analysis conWrmed the deletion. Deleted probes: MAPT
and KIAA1267. c Picture of the eyes of case 2, characterized by bleph-
arophimosis, bilateral upper lid ptosis, epicanthus inversus and tele-
canthus123
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(8.6 Mb) and a terminal duplication of chromosome 6p
were observed (7.7 Mb) (Fig. 3a). Her facial appearance is
characterized by blepharophimosis, ptosis, Xattened and
broad nose, long philtrum (IV-2) (Fig. 3d). In addition she
displays psychomotor retardation. Patients with a terminal
deletion of the short arm of chromosome 3 have been
described to display blepharophimosis, epicanthus,
upturned nose, long philtrum, microcephaly and polydac-
tyly (Malmgren et al. 2007). Both the terminal deletion of
3p and terminal duplication 6p are associated with BPES-
like features according to literature (Schinzel 2001). With
standard G-banding the deletion and duplication were not
visible. FISH with DNA probes speciWc for the subtelo-
meric region of chromosome 3p and 6p revealed that this
rearrangement arose by an unbalanced translocation
between chromosome 3p and 6p (Fig. 3b). Furthermore,
another patient of this family with similar clinical features
was found to have the same unbalanced rearrangement
using SNP array analysis (III-5) (Fig. 3d). Subsequently,
segregation analysis of the 3;6 translocation was performed
in other members by FISH analysis (Fig. 3c), and revealed
a familial 3;6 translocation. An unbalanced translocation,
resulting in a terminal duplication of chromosome 3p and a
terminal deletion of chromosome 6p, was observed in one
family member (V-2). This patient showed no blepharophi-
mosis, but displayed macrocephaly, Dandy–Walker malfor-
mation, hypoplasia of the cerebellum, hypertelorism,
divergent strabismus, broad and Xat nasal bridge and low
set ears (Fig. 3d).
Previously performed conventional karyotyping revealed
no chromosome abnormalities in patients 7, 8 and 9. These
Wndings demonstrate that even large chromosomal imbal-
ances are not always easily detected with standard G-banding,
emphasizing the importance of a whole-genome screen
with a high resolution array technique.
Candidate gene analysis
Assuming that the identiWed CNVs are causative for BPES-
like phenotypes, it can be postulated that the corresponding
chromosomal regions might reveal some relevant candidate
genes contributing to some speciWc features. Most of these
rearrangements, however, are too large to allow pinpointing
of major candidate genes. Despite this, we used the software
tool Anni in order to Wnd functional associations between
large numbers of genes contained in the identiWed CNVs and
biomedical information from literature (Jelier et al. 2007).
However, for all these regions no signiWcant candidate genes
were found. The availability of more BPES-like patients and
more subtle rearrangements may be useful in the search for
candidate genes involved in BPES-like phenotypes.
Fig. 2 Case 4. a Deletion of 
chromosome 10p12.33-p12.31 
(4.5 Mb) detected with AVyme-
trix GeneChip Human Mapping 
262 K NspI. b FISH analysis 
conWrmed the deletion. Control 
probe: RP11-390B4 (red), 
deleted probe 10p12.31: 
RP11-177H22 (green). 
c Facial picture of case 4, 
showing blepharophimosis, 
ptosis, epicanthal folds, 
ectropion of the lower eyelid, 
S-shaped upper eyelid, 
synophrys123
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BPES-like features are associated with many syndromes
and chromosomal disorders. In this study novel rearrange-
ments were identiWed in 33% of patients with BPES-like
phenotypes. These changes are presumed to contribute to
the phenotype in most cases. Overall, we demonstrated that
whole-genome high-density array screening is a powerful
strategy to reveal the underlying genetic defect in BPES-
like phenotypes. We conclude that patients with all four
Fig. 3 Case 9. a Terminal dele-
tion of chromosome 3p25.3 
(8.6 Mb) and terminal duplica-
tion of 6p24.3 (7.7 Mb) detected 
with the Illumina’s Sentrix Hu-
manHap300 Genotyping Bead-
chip. The derivative 
chromosome 3 was not observed 
by conventional G-banding. 
b FISH analysis revealed the 
presence of an unbalanced 3;6 
translocation. Left panel, control 
probe: CEP3 (red) (Vysis), 6pter 
probe: GS-196I5 (green); right 
panel, control probe: CEP3 (red) 
(Vysis), 3pter probe; GS-
186B18 (green). c Pedigree of 
the family with the segregating 
t(3;6) analyzed with FISH 
experiments. half-Wlled square: 
balanced t(3;6); Wlled square 
3p25.3 deletion and 6p24.3 
duplication; stripped square: 
3p25.3 duplication and 6p24.3 
deletion. d Facial picture of case 
9 (IV-2), characterized by bleph-
arophimosis, ptosis, Xattened 
and broad nose. Facial pictures 
of two relatives (III-5, IV-13) 
with the same unbalanced trans-
location as case 9 are presented. 
These members show similar 
clinical features. In addition, a 
facial picture of a relative (V-2) 
with the opposite unbalanced 
translocation is shown. No 
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genetic defects in FOXL2. However, patients with a BPES-
like phenotype that can be distinguished from typical
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